Anesthesia in the obese patient: Pharmacokinetic considerations

Journal of Clinical Anesthesia

Volumn 17, Issue 2, 2005, Pages 134-145

  Casati, Andrea ^a,b   Putzu, Marta ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Azienda Ospendaliera di Parma   (Italy)

Author keywords

Obesity; Pharmacokinetics

Indexed keywords

ALFENTANIL; ALPRAZOLAM; ANESTHETIC AGENT; ATRACURIUM; BENZODIAZEPINE; DESFLURANE; DIAZEPAM; DOXACURIUM; ENFLURANE; FENTANYL; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LIPID; LOCAL ANESTHETIC AGENT; LORAZEPAM; METHOXYFLURANE; MIDAZOLAM; MUSCLE RELAXANT AGENT; NITRAZEPAM; OPIATE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; VECURONIUM;

ADIPOSE TISSUE; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHESIST; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DOSE CALCULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG HALF LIFE; DRUG SAFETY; DRUG SENSITIVITY; DRUG USE; HEMOCONCENTRATION; HUMAN; HYPOXEMIA; INTRAOPERATIVE PERIOD; LEAN BODY WEIGHT; LIPID SOLUBILITY; LIPOPHILICITY; LUNG VENTILATION; MAINTENANCE DRUG DOSE; OBESITY; PARAMETER; PATIENT; POPULATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SURGICAL PATIENT; TREATMENT PLANNING;

EID: 16244404633     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2004.01.009     Document Type: Review

References (110)

1. P. Bjorntorp Obesity Lancet 350 1997 423 426
2. K.M. Flegal, M.D. Carrol, R.J. Kuczmarski, and C.L. Johnson Overweight and obesity in the United States: Prevalence and trends, 1960-1994 Int. J. Obes. Relat. Metab. Disord. 22 1998 39 47
3. J. Sobal, and A. Stunkard Socioeconomic status of obesity: A review of the literature Psychol. Bull. 105 1989 260 275
4. National Institutes of Health Consensus Development Conference Statement. Health implications of obesity Ann. Intern. Med. 103 1985 147 151
5. G.A. Bray Pathophysiology of obesity Am. J. Clin. Nutr. 55 Suppl. 1992 488 494
6. R.J. Garrison, and W.P. Castelli Weight and thirty-year mortality of men in the Framinghan Study Ann. Intern. Med. 103 1985 1006 1009
7. L.V. Sjostrom Mortality of severely obese subjects Am. J. Clin. Nutr. 55 Suppl. 1992 516 523
8. J. Duflou, R. Virmani, I. Rabin, A. Burke, A. Farb, and J. Smialek Sudden death as a result of heart disease in morbid obesity Am. Heart J. 1995 130 213
9. E.J. Drenick, and J.S. Fisler Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy Am. J. Surg. 155 1988 720 726
10. B.A. Reeder, A. Senthilselvan, and J.P. Despres The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group Can. Med. Assoc. J. 157 Suppl. 1 1997 S30 S45
11. L. Garfinkel Overweight and cancer Ann. Intern. Med. 103 1985 1034 1036
12. M. Fried, M. Pesakova, and M. Kasalicky The role of laparoscopy in the treatment of morbid obesity Obes. Surg. 8 1998 520 531
13. P. Juvin, J.P. Marmuse, and S. Delerme Post-operative course after conventional or laparoscopic gastroplasty in morbidly obese patients Eur. J. Anaesthesiol. 16 1999 400 403
14. R.H. Miles, R.E. Carballo, and R.A. Prinz Laparoscopy, the preferred method of cholecystectomy in morbidly obese Surgery 112 1992 818 823
15. J.P. Adams, and P.G. Murphy Obesity in anaesthesia and intensive care Br. J. Anaesthesiol. 85 2000 91 108
16. G. Torri Gli Anestetici Per Inalazione 1998 Minerva Medica Turin (Italy) [in Italian]
17. D.R. Abernethy, and D.J. Greenblatt Drug disposition in obese humans. An update Clin. Pharmacokinet. 11 1986 199 213
18. G. Cheymol Clinical pharmacokinetics of drugs in obesity. An update Clin. Pharmacokinet. 25 1993 103 114
19. G. Cheymol Effects of obesity on pharmacokinetics implications for drug therapy Clin. Pharmacokinet. 39 2000 215 231
20. A. Maddox, M. Horowitz, J. Wishart, and P. Collins Gastric and oesophageal emptying in obesity Scand. J. Gastroenterol. 24 1989 593 598
21. J. Bolinder, D.A. Kerckhoffs, E. Moberg, E. Hagstrom-Toft, and P. Arner Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects Diabetes 49 2000 797 802
22. K.A. Virtanen, P. Lonnroth, and R. Parkkola Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans J. Clin. Endocrinol. Metab. 87 2002 3902 3910
23. K.M. Vasan, and G. Lopez-Berestein The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers Arch. Med. Res. 24 1993 395 401
24. P. Barbeau, M.S. Litaker, and K.F. Woods Hemostatic and inflammatory markers in obese youths: Effects of exercise and adiposity J. Pediatr. 141 2002 415 420
25. C.L. Derry, P.D. Kroboth, A.L. Pittenger, F.J. Kroboth, S.E. Corey, and R.B. Smith Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men J. Clin. Psychopharmacol. 15 1995 197 205
26. G. Guzzaloni, G. Grugni, A. Minocci, D. Moro, and F. Morabito Liver steatosis in juvenile obesity: Correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test Int. J. Obes. Relat. Metab. Disord. 24 2000 772 776
27. V. Ratziu, P. Giral, and F. Charlotte Liver fibrosis in overweight patients Gastroenterology 118 2000 1117 1123
28. J.R. Henegar, S.A. Bigler, L.K. Henegar, S.C. Tyagi, and J.E. Hall Functional and structural changes in the kidney in the early stages of obesity J. Am. Soc. Nephrol. 12 2001 1211 1217
29. D.E. Salazar, and G.B. Corcoran Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat free body mass Am. J. Med. 84 1988 1053 1060
30. J.E. Hall, E.D. Crook, D.W. Jones, M.R. Wafford, and P.M. Dubbert Mechanism of obesity-associated cardiovascular and renal disease Am. J. Med. Sci. 324 2002 127 137
31. R.D. Snider, J.A. Kruse, J.J. Bander, and G.H. Dunn Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit Pharmacotherapy 15 1995 747 753
32. L. Backman, V. Freyschuss, D. Hallberg, and A. Melcher Cardiovascular function in extreme obesity Acta Med. Scand. 193 1973 437 446
33. V. Palmieri, G. de Simone, and D.K. Arnett Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study) Am. J. Cardiol. 88 2001 1163 1168
34. M.E. Diaz Hypertension and obesity J. Hum. Hypertens. 16 Suppl. 1 2002 18 22
35. M.A. Alpert, C.R. Lambert, and H. Panayiotou Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss Am. J. Cardiol. 75 1995 1194 1197
36. M.A. Alpert, C.R. Lambert, and B.E. Terry Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients Int J. Obes. Relat. Metab. Disord. 19 1995 550 557
37. M.A. Alpert Obesity cariomyopathy: Pathophysiology and evolution of the clinical syndrome Am. J. Med. Sci. 321 2001 225 236
38. C. Ray, D. Sue, G. Bray, J.E. Hansen, and K. Wasserman Effects of obesity on respiratory function Am. Rev. Respir. Dis. 128 1983 501 506
39. M.S. Biring, M.I. Lewis, J.I. Liu, and Z. Mohschifar Pulmonary physiologic changes of morbid obesity Am. J. Med. Sci. 318 1999 293 297
40. P. Pelosi, M. Croci, I. Ravagnan, P. Vicardi, and L. Gattinoni Total respiratory system, lung, and chest wall mechanics in sedated paralyzed postoperative morbidly obese patients Chest 109 1996 144 151
41. P. Pelosi, M. Croci, and I. Ravagnan The effects of body mass on lung volumes, respiratory mechanics, and gas exchange general anesthesia Anesth. Analg. 87 1998 654 660
42. J.O. Auler, E. Miyoshi, C.R. Fernandes, F.E. Bensenor, L. Elias, and J. Bonassa The effects of abdominal opening on respiratory mechanics during general anesthesia in normal and morbidly obese patients: A comparative study Anesth. Analg. 94 2002 741 748
43. L. Dumont, M. Mattys, C. Mardirosoff, N. Vervloesem, J.L. Alle, and J. Massaut Changes in pulmonary mechanics during laparoscopic gastroplasty in morbidly obese patients Acta Anaesthesiol. Scand. 41 1997 408 413
44. A. Casati, L. Comotti, and C. Tommasino Effects of pneumoperitoneum and reverse Trendelenburg position on cardiopulmonary function in morbidly obese patients receiving laparoscopic gastric banding Eur. J. Anaesthesiol. 17 2000 300 305
45. P. Pelosi, I. Ravagnan, and G. Giurati Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis Anesthesiology 91 1999 1221 1231
46. A.S. Eichernberger, S. Proietti, and S. Wicky Morbid obesity and postoperative pulmonary atelectasis: An underestimated problem Anesth. Analg. 95 2002 1788 1792
47. H. Russo, and F. Bressolle Pharmacodynamics and pharmacokinetics of thiopental Clin. Pharmacokinet. 35 1998 95 134
48. L.C. Marck, J.J. Burns, and L. Brand The passage of thiopental and their oxygen analogs into brain J. Pharmacol. Exp. Ther. 123 1958 70 73
49. P.G. Dayton, J.L. Perrel, M.A. Landrau, L. Brand, and L.C. Mark The relationship between binding of thiopental to plasma and its distribution into adipose tissue in man, as measured by spectrophotofluorometric method Biochem. Pharmacol. 16 1967 2321 2326
50. B.B. Brodie, H. Kurts, and L.S. Schanker The importance of dissociation constant and lipid solubility influencing the passage of drugs into the cerebrospinal fluid J. Pharmacol. Exp. Ther. 130 1960 20 25
51. D.K. Rose, M.M. Cohen, D.F. Wigglesworth, and D.P. DeBoer Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. Anesthesiology 81 1994 410 418
52. J.S. Rutherford, M.R. Logan, and G.B. Drummond Changes in end-expiratory lung volume on induction of anaesthesia with thiopentone or propofol Br. J. Anaesth. 73 1994 579 582
53. E. Pizzirani, P. Pigato, and F. Favretti The post-anesthetic recovery in obesity surgery: Comparison between two anesthetic techniques Obes. Surg. 2 1992 91 94
54. D. Jung, M. Mayersohn, D. Perrier, J. Calkins, and R. Saunders Thiopental disposition in lean and obese undergoing surgery Anesthesiology 56 1982 269 274
55. J.W. Dundee, T.H. Hassard, W.A. McGowan, and J. Henshaw The 'induction' dose of thiopentone. A method of study and preliminary illustrative results Anaesthesia 37 1982 1176 1184
56. D.R. Wada, S. Bjorkman, W.F. Ebling, H. Harashima, S.R. Harapat, and D.R. Stanski Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans Anesthesiology 87 1997 884 899
57. J.C. Cloyd, B.D. Wright, and D. Perrier Pharmacokinetic properties of thiopental in two patients treated for uncontrollable seizures Epilepsia 20 1979 313 318
58. J. Kanto, and E. Gepts Pharmacokinetic implications for the clinical use of propofol Clin. Pharmacokinet. 17 1989 308 326
59. P. Juvin, C. Vadam, L. Malek, H. Dupont, J.P. Marmusc, and J.M. Desmonts Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: A prospective, randomized study Anesth. Analg. 91 2000 714 719
60. A.O. Alvarez, A. Cascardo, S. Albarracin Menendez, J.J. Capria, and R.A. Cordero Total intravenous anesthesia with midazolam, remifentanil, propofol and cisatracurium in morbid obesity Obes. Surg. 10 2000 353 360
61. C. Keller, J. Brimacombe, A. Kleinsasser, and L. Brimacombe The laryngeal mask airway proseal as a temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation Anesth. Analg. 94 2002 737 740
62. L. Lind, S. Johansson, and K. Ekman The influence of obesity and fat distribution on induction and maintenance doses of propofol Ups. J. Med. Sci. 98 1993 187 188
63. M. Kakinohana, H. Tomiyama, S. Matsuda, and Y. Okuda Target-controlled propofol infusion for general anesthesia in three obese patients Masui 49 2000 732 735
64. F. Servin, R. Farinotti, J.P. Haberer, and J.M. Desmonts Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study Anesthesiology 78 1993 657 665
65. A. Shafer, V.A. Doze, S.L. Shafer, and P.F. White Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia Anesthesiology 69 1988 348 356
66. M. Kakinohana, H. Tomiyama, S. Matsuda, and Y. Okuda Target-controlled propofol infusion for general anesthesia in three obese patients Masui 49 2000 732 735
67. H. Saijo, O. Nagata, and T. Kitamura Anesthetic management of a hyper-obese patient by target-controlled infusion (TCI) of propofol and fentanyl Masui 50 2001 528 531
68. A. Casati, G. Fanelli, E. Casaletti, E. Colnaghi, V. Cedrati, and G. Torri Clinical assessment of target-controlled infusion of propofol during monitored anesthesia care Can. J. Anaesth. 46 1999 235 239
69. T. Igarashi, O. Nagata, H. Iwakiri, M. Ikeda, S. Uezono, and M. Ozaki Two cases of intraoperative awareness during intravenous anesthesia with propofol in morbidly obese patients Masui 51 2002 1243 1247
70. D.R. Abernethy, D.J. Greenblatt, M. Divoll, and R.I. Shader Prolonged accumulation of diazepam in obesity J. Clin. Pharmacol. 23 1983 369 376
71. D.R. Abernethy, D.J. Greenblatt, M. Divoll, R.B. Smith, and R.I. Shader The influence of obesity on the pharmacokinetics of oral alprazolam and triaolam Clin. Pharmacokinet. 9 1984 177 183
72. D.R. Abernethy, D.J. Greenblatt, A. Locniskar, H.R. Ochs, J.S. Harmatz, and R.I. Shader Obesity effects on nitrazepam disposition Br. J. Clin. Pharmacol. 22 1986 551 557
73. D.J. Greenblatt, D.R. Abernethy, A. Locniskar, J.S. Harmatz, R.A. Limjuco, and R.I. Shader Effect of age, gender, and obesity on midazolam kinetics Anesthesiology 61 1984 27 35
74. J.G. Whitwam Flumazenil and midazolam in anaesthesia Acta Anaesthesiol. Scand. Suppl. 108 1995 15 22
75. R.C. Cork, R.W. Vaughan, and J.B. Bentley General anesthesia for morbidly obese patients-an examination of postoperative outcomes Anesthesiology 54 1981 310 313
76. S.R. Young, R.K. Stoelting, C. Peterson, and J.A. Madura Anesthetic biotransformation and renal function in obese during and after methoxyflurane or halothane anesthesia Anesthesiology 42 1975 451 457
77. J.B. Bentley, R.W. Vaughan, M.S. Miller, J.M. Calkins, and A.J. Gandolfi Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia Anesth. Analg. 58 1979 409 412
78. J.B. Bentley, R.W. Vaughan, A.J. Gandolfi, and R.C. Cork Halothane biotransformation in obese and nonobese patients Anesthesiology 57 1982 94 97
79. M.S. Miller, A.J. Gandolfi, R.W. Vaughan, and J.B. Bentley Disposition of enflurane in obese patients J. Pharmacol. Exp. Ther. 215 1980 292 296
80. P. Juvin, C. Vadam, L. Malek, H. Dupont, J.P. Marmuse, and J.M. Desmonts Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: A prospective randomised study Anesth. Analg. 91 2000 714 719
81. L. Sollazzi, V. Perilli, and C. Modesti Volatile anesthesia in bariatric surgery Obes. Surg. 11 2001 623 626
82. G. Torri, A. Casati, and A. Albertin Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients J. Clin. Anesth. 13 2001 565 570
83. A. Casati, E. Bignami, E. Spreafico, and D. Mamo Effects of obesity on wash-in and wash-out kinetics of sevoflurane Eur. J. Anaesthesiol. 21 2004 243 245
84. Z. Salihoglu, S. Karaca, Y. Kose, K. Zengin, and M. Taskin Total intravenous anesthesia versus single breath technique and anesthesia maintenance with sevoflurane for bariatric operations Obes. Surg. 11 2001 496 501
85. G. Torri, A. Casati, L. Comotti, E. Bignami, and M. Scarioni Wash-in and wash-out curves of sevoflurane and isoflurane in morbidly obese patients Minerva Anestesiol. 68 2002 523 527
86. H. Higuchi, T. Satoh, S. Arimura, M. Kanno, and R. Endon Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia Anesth. Analg. 77 1993 1018 1021
87. E.J. Frink, T.P. Malan, E.A. Brown, S. Morgan, and B.R. Brown Jr. Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and nonobese patients Anesth. Analg. 76 1993 1333 1337
88. M. Behne, H.J. Wilke, and S. Harder Clinical pharmacokinetics of sevoflurane Clin. Pharmacokinet. 36 1999 13 26
89. K. Tsueda, J.E. Warren, L.A. McCafferty, and J.P. Nagle Pancuronium bromide requirement during anesthesia for the morbidly obese Anesthesiology 48 1978 438 439
90. F. Varin, J. Ducharme, Y. Theoret, J.G. Besner, D.R. Bevan, and F. Donati Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium Clin. Pharmacol. Ther. 48 1990 18 25
91. A.E. Schwartz, R.S. Matteo, E. Ornstein, J.D. Halevy, and J. Diaz Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient Anesth. Analg. 74 1992 515 518
92. H. Kirkegaard-Nielsen, H.S. Helbo-Hansen, P. Lindholm, I.K. Severinsen, and H.S. Pedersen Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block Anesth. Analg. 83 1996 1076 1080
93. D.M. Fisher, K.S. Reynolds, and V.D. Schmith The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium Anesth. Analg. 89 1999 786 795
94. F.K. Puhringer, C. Keller, A. Kleinsasser, S. Giesinger, and A. Benzer Pharmacokinetics of rocuronium bromide in obese female patients Eur. J. Anaesthesiol. 16 1999 507 510
95. J.B. Rose, M.C. Theroux, and M.S. Katz The potency of succinylcholine in obese adolescents Anesth. Analg. 90 2000 576 578
96. J.B. Bentley, J.D. Borel, R.W. Vaughan, and A.J. Gandolfi Weight, pseudocholinesterase activity, and succinylcholine requirement Anesthesiology 57 1982 48 49
97. A.E. Schwartz, R.S. Matteo, E. Ornstein, W.L. Young, and K.J. Myers Pharmacokinetics of sufentanil obese patients Anesth. Analg. 73 1991 790 793
98. J. Scholz, M. Steinfath, and M. Schulz Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update Clin. Pharmacokinet. 31 1996 275 292
99. Z. Salihoglu, S. Demiroluk, N. Demirkiran, and Y. Kose Comparison of effects of remifentanil, alfentanil and fentanyl on cardiovascular responses to tracheal intubation in morbidly obese patients Eur. J. Anaesthesiol. 19 2002 125 128
100. T.D. Egan, B. Huizinga, and S.K. Gupta Remifentanil pharmacokinetics in obese versus lean patients Anesthesiology 89 1998 562 573
101. T. Bouillon, and S.L. Shafer Does size matter? Anesthesiology 89 1998 557 560
102. F.P. Buckley, N.B. Robinson, D.A. Simonowitz, and E.P. Dellinger Anaesthesia in the morbidly obese. A comparison of anesthetic and analgesic regimens for upper abdominal surgery Anaesthesia 38 1983 840 851
103. N. Rawal, U. Sjostrand, E. Christofferson, B. Dahlstrom, A. Arvill, and H. Rydman Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese. Influence on postoperative ambulation and pulmonary function Anesth. Analg. 63 1984 583 592
104. K.M. Kuczkowski, and J.L. Benumof Repeat cesarean section in a morbidly obese parturient: A new anesthetic option Acta Anaesthesiol. Scand. 46 2002 753 754
105. W.J. McCulloch, and D.G. Littlewood Influence of obesity on spinal analgesia with isobaric 0.5% bupivacaine Br. J. Anaesth. 58 1986 610 614
106. Q.H. Hogan, R. Prost, A. Kulier, M.L. Taylor, S. Liu, and L. Mark Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure Anesthesiology 84 1996 1341 1349
107. T. Taivainen, M. Tuominen, and P.H. Rosenberg Influence of obesity on the spread of spinal analgesia after injection of plain 0.5% bupivacaine at the L3-4 or L4-5 interspace Br. J. Anaesth. 64 1990 542 546
108. B. Oberg, and T.D. Poulsen Obesity: An anesthetic challenge Acta Anaesthesiol. Scand. 40 1996 191 200
109. R.H. de Jong Local anesthetic pharmacology D.L. Brown Regional Anesthesia and Analgesia 1996 WB Saunders Philadelphia 124 142
110. D.R. Abernethy, and D.J. Greenblatt Lidocaine disposition in obesity Am. J. Cardiol. 53 1984 1183 1186